These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 12398938)

  • 1. Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing.
    Nakata E; Nakanishi T; Kawai A; Asaumi K; Yamaai T; Asano M; Nishida T; Mitani S; Inoue H; Takigawa M
    Bone; 2002 Oct; 31(4):441-7. PubMed ID: 12398938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.
    Ivkovic S; Yoon BS; Popoff SN; Safadi FF; Libuda DE; Stephenson RC; Daluiski A; Lyons KM
    Development; 2003 Jun; 130(12):2779-91. PubMed ID: 12736220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTGF polymorphism associated with systemic sclerosis.
    Gourh P; Mayes MD; Arnett FC
    N Engl J Med; 2008 Jan; 358(3):308-9; author reply 309. PubMed ID: 18203332
    [No Abstract]   [Full Text] [Related]  

  • 4. CTGF polymorphism associated with systemic sclerosis.
    Morita H; Hayashi D; Nagai R
    N Engl J Med; 2008 Jan; 358(3):308; author reply 309. PubMed ID: 18199873
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats.
    Lambi AG; Harris MY; Amin M; Joiner PG; Hilliard BA; Assari S; Popoff SN; Barbe MF
    JBMR Plus; 2023 Sep; 7(9):e10783. PubMed ID: 37701153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Analysis of CCN2 in Experimental Fracture Healing Models.
    Shimo T; Takebe H; Fujii S; Hosoya A
    Methods Mol Biol; 2023; 2582():335-342. PubMed ID: 36370361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.
    Fu M; Peng D; Lan T; Wei Y; Wei X
    Acta Pharm Sin B; 2022 Apr; 12(4):1740-1760. PubMed ID: 35847511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target.
    Tang L; Xu M; Zhang L; Qu L; Liu X
    Onco Targets Ther; 2020; 13():7411-7422. PubMed ID: 32801764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking CCN2 preferentially inhibits osteoclastogenesis induced by repetitive high force bone loading.
    Barbe MF; Amin M; Gingery A; Lambi AG; Popoff SN
    Connect Tissue Res; 2021 Jan; 62(1):115-132. PubMed ID: 32683988
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of
    Keenan CM; Ramos-Mucci L; Kanakis I; Milner PI; Leask A; Abraham D; Bou-Gharios G; Poulet B
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32616521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin.
    Takigawa M
    J Cell Commun Signal; 2018 Mar; 12(1):253-264. PubMed ID: 29076115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramethylpyrazine inhibits CTGF and Smad2/3 expression and proliferation of hepatic stellate cells.
    Li J; Dong N; Cheng S; Li X; Wang W; Xiang Y
    Biotechnol Biotechnol Equip; 2015 Jan; 29(1):124-131. PubMed ID: 26019625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification.
    Khattab HM; Aoyama E; Kubota S; Takigawa M
    J Cell Commun Signal; 2015 Sep; 9(3):247-54. PubMed ID: 25895141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN2: a master regulator of the genesis of bone and cartilage.
    Takigawa M
    J Cell Commun Signal; 2013 Aug; 7(3):191-201. PubMed ID: 23794334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts.
    Geisinger MT; Astaiza R; Butler T; Popoff SN; Planey SL; Arnott JA
    PLoS One; 2012; 7(4):e35258. PubMed ID: 22539964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis.
    Ouellet V; Siegel PM
    J Cell Commun Signal; 2012 Jun; 6(2):73-85. PubMed ID: 22427255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.
    Jun JI; Lau LF
    Nat Rev Drug Discov; 2011 Dec; 10(12):945-63. PubMed ID: 22129992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.
    Arnott JA; Lambi AG; Mundy C; Hendesi H; Pixley RA; Owen TA; Safadi FF; Popoff SN
    Crit Rev Eukaryot Gene Expr; 2011; 21(1):43-69. PubMed ID: 21967332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN1/CYR61: the very model of a modern matricellular protein.
    Lau LF
    Cell Mol Life Sci; 2011 Oct; 68(19):3149-63. PubMed ID: 21805345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CCN2 in cartilage and bone development.
    Kubota S; Takigawa M
    J Cell Commun Signal; 2011 Aug; 5(3):209-17. PubMed ID: 21484188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.